#350 Not a Dry Eye in the House – Looking into Artificial Tears
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
- Two systematic reviews with 43-64 randomized controlled trials (RCTs) reviewed individually for patient-oriented outcomes. Most excluded post-surgical and contact lens wearers.1,2
- Artificial tears versus “placebo”/no-treatment:
- RCT (304 patients): Symptoms like dryness/soreness (scale 0-15, higher worse, baseline ~8).3
- At 28 days: 5.7 sodium hyaluronate versus 6.1 saline drops, statistically but not clinically different.
- RCT (27 computer-users, many without dry eyes) compared three different artificial tears to ‘no product’.4
- All interventions, including ‘no product,’ reduced patient symptoms, without difference between groups.
- RCT (304 patients): Symptoms like dryness/soreness (scale 0-15, higher worse, baseline ~8).3
- Artificial tears versus each other:
- Validated patient symptom scale (0-100, higher worse, minimal clinically important difference=4.5): 18 RCTs; 27-445 patients with moderate-severe dry eyes. Of 36 different comparisons,1,2 three were statistically different:
- Industry funded RCT (40 patients): At 90 days, cross-linked hyaluronic acid/coenzyme Q10 combination improved 16 points versus 8 points for hyaluronic acid alone.5
- RCT (110 patients): At 30 days, final scores differed by 3 points (biased by differing baselines).6
- RCT (120 patients): 12-week scores for sterile isotonic seawater washes were 4.5 points better than carmellose drops.7
- Other patient-oriented symptom scores, 6 RCTs with ≥100 patients.3,8-12 One statistically different:
- 135 patients, hypotonic 0.4% hyaluronic acid versus 0.3% hydroxypropylmethylcellulose. Example: Proportion attaining ‘mild or resolved’ burning or foreign body sensation at 60 days: 19%-36% more patients on hyaluronic acid.10
- Validated patient symptom scale (0-100, higher worse, minimal clinically important difference=4.5): 18 RCTs; 27-445 patients with moderate-severe dry eyes. Of 36 different comparisons,1,2 three were statistically different:
- Preservative versus preservative-free artificial tears:
- Systematic review (2 RCTs, 271 patients): No difference.13
- Artificial tears versus “placebo”/no-treatment:
- Limitations: High risk of funding bias,5,10 chance findings (many RCTs, differences rare), and some biased analyses.6,10
- Over-the-counter product costs vary (<$10 to >$50) with preservative-free typically being more expensive.14
- Guideline recommends preservative-free products if intolerant to preservative, soft/hybrid contact lens wearers, use of other eye topicals with preservative, or if drops required ≥4 times/day.15
- Non-topical interventions include warm compresses and lid hygiene.16
Good to know
Once again the OTC industry selling placebo.
Is there a real problem with NOT treating dry eye? Regardless of symptom relief (or not) with whatever product, what are the sequelae of untreated dry eyes?
Helpful study
I am surprised by these results. My optometrist and ophthalmologist both suggested the drops.
Reasonable to present to patients and leave it to them.
Perhaps personal preference is influenced by the treatment outcome for the product used- with or with preservatives.